KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) EBT (2016 - 2025)

Cvs Health (CVS) has disclosed EBT for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 36.31% year-over-year to $1.4 billion, compared with a TTM value of $2.1 billion through Dec 2025, down 65.26%, and an annual FY2025 reading of $2.1 billion, down 65.26% over the prior year.
  • EBT was $1.4 billion for Q4 2025 at Cvs Health, up from -$3.5 billion in the prior quarter.
  • Across five years, EBT topped out at $4.0 billion in Q2 2022 and bottomed at -$4.5 billion in Q3 2022.
  • Average EBT over 5 years is $1.8 billion, with a median of $2.5 billion recorded in 2023.
  • The sharpest move saw EBT soared 167.75% in 2023, then tumbled 3416.19% in 2025.
  • Year by year, EBT stood at $1.7 billion in 2021, then skyrocketed by 86.72% to $3.2 billion in 2022, then decreased by 14.13% to $2.7 billion in 2023, then fell by 21.4% to $2.1 billion in 2024, then plummeted by 36.31% to $1.4 billion in 2025.
  • Business Quant data shows EBT for CVS at $1.4 billion in Q4 2025, -$3.5 billion in Q3 2025, and $1.6 billion in Q2 2025.